Regional cortical thinning predicts worsening apathy and hallucinations across the alzheimer disease spectrum

American Journal of Geriatric Psychiatry

Volumn 22, Issue 11, 2014, Pages 1168-1179

  Donovan, Nancy J ^a   Wadsworth, Lauren P ^a   Lorius, Natacha ^a   Locascio, Joseph J ^a   Rentz, Dorene M ^a   Johnson, Keith A ^a   Sperling, Reisa A ^a   Marshall, Gad A ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Alzheimer disease; Apathy hallucinations; cortical thinning; CSF biomarkers; MRI

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; APOLIPOPROTEIN E; TAU PROTEIN; AMYLOID BETA PROTEIN; AMYLOID BETA-PROTEIN (1-42); BIOLOGICAL MARKER; PEPTIDE FRAGMENT;

AGED; ALZHEIMER DISEASE; APATHY; ARTICLE; BRAIN CORTEX ATROPHY; BRAIN REGION; CEREBROSPINAL FLUID; CORTICAL THICKNESS (BRAIN); CROSS-SECTIONAL STUDY; DISEASE SEVERITY; FEMALE; HALLUCINATION; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE ASSESSMENT; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHIATRIC INVENTORY QUESTIONNAIRE; NORTH AMERICA; NUCLEAR MAGNETIC RESONANCE IMAGING; BRAIN CORTEX; CLINICAL TRIAL; COMPLICATION; HALLUCINATIONS; MULTICENTER STUDY; NEUROIMAGING; NEUROPSYCHOLOGICAL TEST; PATHOLOGY;

AGED; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; APATHY; BIOLOGICAL MARKERS; CEREBRAL CORTEX; CROSS-SECTIONAL STUDIES; FEMALE; HALLUCINATIONS; HUMANS; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; NEUROIMAGING; NEUROPSYCHOLOGICAL TESTS; PEPTIDE FRAGMENTS; TAU PROTEINS;

EID: 84921510703     PISSN: 10647481     EISSN: 15457214     Source Type: Journal    
DOI: 10.1016/j.jagp.2013.03.006     Document Type: Article

References (41)

1. Wadsworth LP, Lorius N, Donovan NJ, et al: Neuropsychiatric symptoms and global functional impairment along the Alzheimer's continuum. Dement Geriatr Cogn Disord 2012; 34: 96-111
2. Boyle PA, Malloy PF, Salloway S, et al: Executive dysfunction and apathy predict functional impairment in Alzheimer disease. Am J Geriatr Psychiatry 2003; 11:214-221
3. Scarmeas N, Brandt J, Albert M, et al: Delusions and hallucinations are associated with worse outcome in Alzheimer disease. Arch Neurol 2005; 62:1601-1608
4. Lyketsos CG, Lopez O, Jones B, et al: Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: Results from the cardiovascular health study. JAMA 2002; 288: 1475-1483
5. Ropacki SA, Jeste DV: Epidemiology of and risk factors for psychosis of Alzheimer's disease: A review of 55 studies published from 1990 to 2003. Am J Psychiatry 2005; 162:2022-2030
6. Wilson RS, Gilley DW, Bennett DA, et al: Hallucinations, delusions, and cognitive decline in Alzheimer's disease. J Neurol Neurosurg Psychiatry 2000; 69:172-177
7. Bakkour A, Morris JC, Dickerson BC: The cortical signature of prodromal AD: Regional thinning predicts mild AD dementia. Neurology 2009; 72:1048-1055
8. Dickerson BC, Wolk DA: MRI cortical thickness biomarker predicts AD-like CSF and cognitive decline in normal adults. Neurology 2012; 78:84-90
9. Putcha D, Brickhouse M, O'Keefe K, et al: Hippocampal hyperactivation associated with cortical thinning in Alzheimer's disease signature regions in non-demented elderly adults. J Neurosci 2011; 31:17680-17688
10. Tosun D, Schuff N, Shaw LM, et al: Relationship between CSF biomarkers of Alzheimer's disease and rates of regional cortical thinning in ADNI data. J Alzheimers Dis 2011; 26(suppl 3):77
11. Lanctot KL, Moosa S, Herrmann N, et al: A SPECT study of apathy in Alzheimer's disease. Dement Geriatr Cogn Disord 2007; 24: 65-72
12. Robert PH, Darcourt G, Koulibaly MP, et al: Lack of initiative and interest in Alzheimer's disease: A single photon emission computed tomography study. Eur J Neurol 2006; 13:729-735
13. Benoit M, Clairet S, Koulibaly PM, et al: Brain perfusion correlates of the apathy inventory dimensions of Alzheimer's disease. Int J Geriatr Psychiatry 2004; 19:864-869
14. Migneco OBM, Koulibaly PM, Dygai I, et al: Perfusion brain SPECT and statistical parametric mapping analysis indicate that apathy is a cingulate syndrome: A study in Alzheimer's disease and nondemented patients. Neuroimage 2001; 13:896-902
15. Marshall GA, Monserratt L, Harwood D, et al: Positron emission tomography metabolic correlates of apathy in Alzheimer disease. Arch Neurol 2007; 64:1015-1020
16. Apostolova LG, Akopyan GG, Partiali N, et al: Structural correlates of apathy in Alzheimer's disease. Dement Geriatr Cogn Disord 2007; 24:91-97
17. Tunnard C, Whitehead D, Hurt C, et al: Apathy and cortical atrophy in Alzheimer's disease. Int J Geriatr Psychiatry 2011; 26: 741-748
18. Kim JW, Lee DY, Choo IH, et al: Microstructural alteration of the anterior cingulum is associated with apathy in Alzheimer disease. Am J Geriatr Psychiatry 2011; 19:644-653
19. Moran EK, Becker JA, Satlin A, et al: Psychosis of Alzheimer's disease: Gender differences in regional perfusion. Neurobiol Aging 2008; 29:1218-1225
20. Mega MS, Lee L, Dinov ID, et al: Cerebral correlates of psychotic symptoms in Alzheimer's disease. J Neurol Neurosurg Psychiatry 2000; 69:167-171
21. Kotrla KJ, Chacko RC, Harper RG, et al: Clinical variables associated with psychosis in Alzheimer's disease. Am J Psychiatry 1995; 152:1377-1379
22. Lopez OL, Smith G, Becker JT, et al: The psychotic phenomenon in probable Alzheimer's disease: A positron emission tomography study. J Neuropsychiatry Clin Neurosci 2001; 13:50-55
23. Holroyd S, Shepherd ML, Downs JH 3rd: Occipital atrophy is associated with visual hallucinations in Alzheimer's disease. J Neuropsychiatry Clin Neurosci 2000; 12:25-28
24. Weiner MW, Veitch DP, Aisen PS, et al: The Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception. Alzheimers Dement 2012; 8(1 suppl):S1-68
25. Rosen WG, Terry RD, Fuld PA, et al: Pathological verification of ischemic score in differentiation of dementias. Ann Neurol 1980; 7:486-488
26. Sheikh JI, Yesavage J: Geriatric Depression Scale (GDS): Recent Evidence and Development of a Shorter Version. New York, The Haworth Press, 1986
27. Marshall GA, Rentz DM, Frey MT, et al: Executive function and instrumental activities of daily living in mild cognitive impairment and Alzheimer's disease. Alzheimers Dement 2011; 7:300-308
28. Kaufer DI, Cummings JL, Ketchel P, et al: Validation of the NPI-Q, a brief clinical form of the Neuropsychiatric Inventory. J Neuropsychiatry Clin Neurosci 2000; 12:233-239
29. Nelson HE, O'Connell A: Dementia: The estimation of premorbid intelligence levels using the New Adult Reading Test. Cortex 1978; 14:234-244
30. Rey A: L'examen clinique en psychologie. Paris, Presses Universitaires De France, 1964
31. Wechsler D: WAIS R manual. New York, The Psychological Corporation, 1981
32. Shaw LM, Vanderstichele H, Knapik-Czajka M, et al: Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects. Ann Neurol 2009; 65: 403-413
33. Olsson A, Vanderstichele H, Andreasen N, et al: Simultaneous measurement of beta-amyloid(1-42), total tau, and phosphorylated tau (Thr181) in cerebrospinal fluid by the xMAP technology. Clin Chem 2005; 51:336-345
34. Starkstein SE, Jorge R, Mizrahi R, et al: A prospective longitudinal study of apathy in Alzheimer's disease. J Neurol Neurosurg Psychiatry 2006; 77:8-11
35. Bruen PD, McGeown WJ, Shanks MF, et al: Neuroanatomical correlates of neuropsychiatric symptoms in Alzheimer's disease. Brain 2008; 131(Pt 9):2455-2463
36. Landes AM, Sperry SD, Strauss ME, et al: Apathy in Alzheimer's disease. J Am Geriatr Soc 2001; 49:1700-1707
37. McDonald CR, McEvoy LK, Gharapetian L, et al: Regional rates of neocortical atrophy from normal aging to early Alzheimer disease. Neurology 2009; 73:457-465
38. Kotrla KJ, Chacko RC, Harper RG, et al: SPECT findings on psychosis in Alzheimer's disease. Am J Psychiatry 1995; 152: 1470-1475
39. Blanc F, Noblet V, Philippi N, et al: Hallucinations and Alzheimer's disease, correlations to brain volume and metabolism: A study of the ADNI cohort. Alzheimers Dement 2011; 7(4, supplement): S731
40. Lin SH, Yu CY, Pai MC: The occipital white matter lesions in Alzheimer's disease patients with visual hallucinations. Clin Imaging 2006; 30:388-393
41. Skogseth R, Mulugeta E, Jones E, et al: Neuropsychiatric correlates of cerebrospinal fluid biomarkers in Alzheimer's disease. Dement Geriatr Cogn Disord 2008; 25:559-563